Latest News and Press Releases
Want to stay updated on the latest news?
-
TARRYTOWN, N.Y., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has completed enrollment in its Phase 2b clinical trial of its ultra-orphan...
-
TARRYTOWN, N.Y., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced appointment of Patrick Fabbio as Chief Financial Officer. Mr. Fabbio, the...
-
TARRYTOWN, N.Y., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat cancer, announced...
-
TARRYTOWN, N.Y., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced results of operations for the quarter and nine months ended September 30, 2015. ...
-
TARRYTOWN, N.Y., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company developing innovative ways to target and treat cancer, announced today that...
-
-EXINI’s Imaging Analysis Software Development Capabilities Complement Progenics’s Portfolio of Imaging Agents and Therapeutics- ...
-
TARRYTOWN, N.Y., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced the presentation of additional data from a Phase 2 trial of its PSMA-targeted...
-
TARRYTOWN, N.Y., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX) today announced that data from its Phase 2 study of Azedra for the treatment of ultra-orphan...
-
TARRYTOWN, N.Y., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX) announced today that it will host a Research and Development (R&D) Day for investors and analysts...
-
TARRYTOWN, N.Y., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced results of operations for the second quarter and six months ended June 30, 2015. "We...